Dace N Almane1, Jana E Jones1, Taylor McMillan1, Carl E Stafstrom2, David A Hsu1, Michael Seidenberg3, Bruce P Hermann1, Temitayo O Oyegbile4. 1. Department of Neurology, University of Wisconsin School of Medicine and Public Health, Madison Wisconsin. 2. Department of Neurology, Johns Hopkins School of Medicine, Baltimore Maryland. 3. Rosalind Franklin University of Medicine and Science, Chicago Illinois. 4. Department of Pediatrics and Neurology, Georgetown University, Washington District of Columbia. Electronic address: too3@georgetown.edu.
Abstract
BACKGROUND: Accumulating evidence suggests that considerable cognitive and psychiatric comorbidity is associated with juvenile myoclonic epilepsy, for which the etiology remains controversial. Our goal was to comprehensively characterize the status of multiple neurobehavioral comorbidities in youth with new- or recent-onset juvenile myoclonic epilepsy, before effects of chronic seizures and medications. METHODS: A total of 111 children aged eight to 18 years (41 new- or recent-onset juvenile myoclonic epilepsy and 70 first-degree cousin controls) underwent neuropsychological assessment (attention, executive, verbal, perceptual, speed), structured review of need for supportive academic services, parent reports of behavior and executive function (Child Behavior Checklist and Behavior Rating Inventory of Executive Function), and formal structured psychiatric interview and diagnosis (Kiddie Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version). RESULTS: Children with juvenile myoclonic epilepsy performed worse than controls across all tested cognitive domains (F(1,105) = 3.85, P < 0.01), utilized more academic services (47% versus 19%, P = 0.002), had more parent-reported behavioral problems and dysexecutive function with lower competence (P < 0.001), and had a higher prevalence of current Axis I diagnoses (attention-deficit/hyperactivity disorder, depression, and anxiety; 54% versus 23%, P = 0.001). Academic and psychiatric problems occurred antecedent to epilepsy onset compared with comparable timeline in controls. CONCLUSION: Comprehensive assessment of cognitive, academic, behavioral, and psychiatric comorbidities in youth with new- or recent-onset juvenile myoclonic epilepsy reveals a pattern of significantly increased neurobehavioral comorbidities across a broad spectrum of areas. These early evident comorbidities are of clear clinical importance with worrisome implications for future cognitive, behavioral, and social function. It is important for health care providers to avoid delays in intervention by assessing potential comorbidities early in the course of the disorder to optimize their patients' social, academic and behavioral progress.
BACKGROUND: Accumulating evidence suggests that considerable cognitive and psychiatric comorbidity is associated with juvenile myoclonic epilepsy, for which the etiology remains controversial. Our goal was to comprehensively characterize the status of multiple neurobehavioral comorbidities in youth with new- or recent-onset juvenile myoclonic epilepsy, before effects of chronic seizures and medications. METHODS: A total of 111 children aged eight to 18 years (41 new- or recent-onset juvenile myoclonic epilepsy and 70 first-degree cousin controls) underwent neuropsychological assessment (attention, executive, verbal, perceptual, speed), structured review of need for supportive academic services, parent reports of behavior and executive function (Child Behavior Checklist and Behavior Rating Inventory of Executive Function), and formal structured psychiatric interview and diagnosis (Kiddie Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version). RESULTS:Children with juvenile myoclonic epilepsy performed worse than controls across all tested cognitive domains (F(1,105) = 3.85, P < 0.01), utilized more academic services (47% versus 19%, P = 0.002), had more parent-reported behavioral problems and dysexecutive function with lower competence (P < 0.001), and had a higher prevalence of current Axis I diagnoses (attention-deficit/hyperactivity disorder, depression, and anxiety; 54% versus 23%, P = 0.001). Academic and psychiatric problems occurred antecedent to epilepsy onset compared with comparable timeline in controls. CONCLUSION: Comprehensive assessment of cognitive, academic, behavioral, and psychiatric comorbidities in youth with new- or recent-onset juvenile myoclonic epilepsy reveals a pattern of significantly increased neurobehavioral comorbidities across a broad spectrum of areas. These early evident comorbidities are of clear clinical importance with worrisome implications for future cognitive, behavioral, and social function. It is important for health care providers to avoid delays in intervention by assessing potential comorbidities early in the course of the disorder to optimize their patients' social, academic and behavioral progress.
Authors: J Kaufman; B Birmaher; D Brent; U Rao; C Flynn; P Moreci; D Williamson; N Ryan Journal: J Am Acad Child Adolesc Psychiatry Date: 1997-07 Impact factor: 8.829
Authors: Tatiana Frascareli Pascalicchio; Gerardo M de Araujo Filho; Maria Helena da Silva Noffs; Katia Lin; Luís Otávio S F Caboclo; Marcos Vidal-Dourado; Laura M F Ferreira Guilhoto; Elza Márcia Targas Yacubian Journal: Epilepsy Behav Date: 2007-01-26 Impact factor: 2.937
Authors: David W Dunn; C S Johnson; S M Perkins; P S Fastenau; A W Byars; T J deGrauw; J K Austin Journal: Epilepsy Behav Date: 2010-11 Impact factor: 2.937
Authors: Kelly Cristina de Carvalho; Carina Gonçalves Pedroso Uchida; Mirian Salvadori Bittar Guaranha; Laura Maria F F Guilhoto; Peter Wolf; Elza Márcia Targas Yacubian Journal: Seizure Date: 2016-06-15 Impact factor: 3.184
Authors: Betul Baykan; Iris E Martínez-Juárez; Ebru A Altindag; Carol S Camfield; Peter R Camfield Journal: Epilepsy Behav Date: 2013-07 Impact factor: 2.937
Authors: Temitayo Oyegbile-Chidi; Danielle Harvey; Jordan Eisner; David Dunn; Jana Jones; Anna Byars; Bruce Hermann; Joan Austin Journal: Front Neurol Date: 2022-07-26 Impact factor: 4.086